Stephen R Quake

Stanford, CA, United States of America

Stephen R Quake

USPTO Granted Patents = 195 

 

 

Average Co-Inventor Count = 2.9

ph-index = 56

Forward Citations = 11,887(Granted Patents)

Forward Citations (Not Self Cited) = 10,883(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • New York, NY (US) (2006)
  • Pasadena, CA (US) (1999 - 2012)
  • San Mateo, CA (US) (2014)
  • Palo Alto, CA (US) (2016 - 2018)
  • San Marino, CA (US) (2001 - 2019)
  • San Francisco, CA (US) (2022 - 2023)
  • Stanford, CA (US) (2007 - 2024)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Sequencing
Cell-Free Rna Profiling
Fetal Genetic Screening
Microfluidic Devices
Noninvasive Diagnostics
Immune Diversity Measurement
Epigenetic Imaging
Allergen-Specific Antibodies
Transplant Rejection Diagnosis
Human Microbiome Analysis
High-Throughput Screening
Elastomeric Valve Systems
195 patents (USPTO):Explore Patents

Title: Stephen R Quake: Revolutionizing Biology and Medicine Through Microfluidics

Introduction:

Microfluidics is a rapidly advancing field that focuses on manipulating and analyzing small volumes of fluids at the microscale level. Among the pioneers in this field, Stephen R Quake's groundbreaking work has revolutionized the realms of biology and medicine. With a remarkable number of patents and influential contributions, Quake's innovative techniques have had a profound impact on scientific research and healthcare advancements.

Latest Patents:

Stephen R Quake, with his expertise in microfluidics, has recently obtained patents that demonstrate his dedication to solving critical challenges in biology and medicine. His patented inventions include:

1. Identifying human B cells expressing anti-allergen antibodies:

These methods aim to generate human monoclonal antibodies that specifically bind to allergens. The antibodies are derived from sequences discovered in isolated single B cells from individuals who experience allergies. By identifying and targeting these antibodies, novel strategies for allergy treatment and prevention can be developed.

2. Non-invasive diagnosis of graft rejection in organ transplant patients:

This patent introduces methods, devices, compositions, and kits for diagnosing or predicting the status and outcome of transplants in patients. By utilizing Quake's microfluidic techniques, this innovation enables non-invasive monitoring of organ transplant rejection, leading to improved patient care and timely intervention.

Career Highlights:

Stephen R Quake's illustrious career is marked by numerous achievements and contributions to the field of microfluidics. As a leading researcher, he has held positions at esteemed institutions, including the California Institute of Technology and Stanford University. Throughout his journey, Quake has been committed to pushing the boundaries of knowledge and translating his discoveries into practical applications.

Collaborations:

In his quest for innovation, Quake has collaborated with esteemed colleagues, including Hou-Pu Chou and Carl L Hansen, who have played significant roles in supporting his research endeavors. By joining forces with fellow scientists, Quake has fostered an environment of collaboration and knowledge exchange, leading to further advancements in microfluidic technologies.

Conclusion:

Stephen R Quake's pioneering work in microfluidics has transformed the landscape of biology and medicine. Through his numerous patents, he has demonstrated a deep commitment to improving healthcare outcomes and pushing the boundaries of scientific knowledge. With continued research and collaboration, Quake's innovative contributions are set to revolutionize the field further, paving the way for exciting developments in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…